Scott C. Weaver

TL;DR: A single-dose, bivalent experimental vaccine based on a chimeric vesicular stomatitis virus that expresses the CHIKV envelope polyprotein in place of the VSV glycoprotein and also expresses the membrane-envelope (ME) glycoproteins of ZIKV could provide durable, low-cost protection against both chikungunya virus and Zika virus for people traveling to or living in areas where both viruses are circulating.

TL;DR: In this discussion paper, 14 senior virologists, including six Life members of the ICTV, compare the present and proposed new definition and recommend that the existing definition of virus species should be retained.

TL;DR: This Review highlights key features of alphaviruses that are known to cause arthritic disease in humans and outlines the present findings pertaining to classification, immunogenicity, pathogenesis, and experimental approaches aimed at limiting disease manifestations.

TL;DR: This IRES-based vaccine was unable to establish productive infection in mosquito cell cultures or in intrathoracically injected Aedes taeniorhynchus, demonstrating that it cannot be transmitted from a vaccinee.

TL;DR: A proposal has been posted on the ICTV website to replace virus species names by non-Latinized binomial names consisting of the current italicized species name with the terminal word “virus” replaced by the Italicized and non-capitalized genus name to which the species belongs.